국내 요양병원 고위험의약품 목록 도출
Developing National Level High Alert Medication Lists for Long-Term Care Patients
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background : High-alert medications (HAMs), the prominent cause of medication harm, can have serious consequences for patients. They should be developed and managed according to institutions. However, HAMs for long-term care (LTC) hospitals presented in hospital accreditation standards in Korea are based on the list of HAMs of acute care hospitals. The aim of this study was to develop a national-level list of high-alert medications for LTC hospitals. Methods : A combined strategy of literature review, epidemiological data analysis of medication error-related incidents, medication utilization, and a survey of expert opinions was applied. We identified candidates of HAMs for LTC from the Institute for Safe Medication Practices (ISMP) and the list of Korean hospital accreditation standards. We analyzed the following database to identify medication error and utilization: the Korea Patients Safety Reporting & Learning System (KOPS) and Korea Adverse Event Reporting System (KAERS), and sample data from national claims. Seven experts working in LTC hospitals evaluated the adequacy and priority of candidate medications. Results : We derived a final list of 16 high-alert medications, including six essential medications (insulin vials, heparin and low molecular weight heparins, hypertonic sodium chloride solutions, concentrated potassium injections, concentrated magnesium injections, and oral chemotherapeutic agents) and 10 optional medications (insulin pens, oral anticoagulants, immunosuppressants, parenteral nutrients for central veins, parenteral chemotherapeutic agents, parenteral benzodiazepines, contrast agents, phenytoin, epinephrine injections, and oral digoxin). Conclusion : We developed a list of high-alert medications for LTC settings at the national level, which may improve medication use and safety in patients who receive LTC.
Abstract
Background : High-alert medications (HAMs), the prominent cause of medication harm, can have serious consequences for patients. They should be developed and managed according to institutions. However, HAMs for long-term care (LTC) hospitals presented in hospital accreditation standards in Korea are based on the list of HAMs of acute care hospitals. The aim of this study was to develop a national-level list of high-alert medications for LTC hospitals. Methods : A combined strategy of literature review, epidemiological data analysis of medication error-related incidents, medication utilization, and a survey of expert opinions was applied. We identified candidates of HAMs for LTC from the Institute for Safe Medication Practices (ISMP) and the list of Korean hospital accreditation standards. We analyzed the following database to identify medication error and utilization: the Korea Patients Safety Reporting & Learning System (KOPS) and Korea Adverse Event Reporting System (KAERS), and sample data from national claims. Seven experts working in LTC hospitals evaluated the adequacy and priority of candidate medications. Results : We derived a final list of 16 high-alert medications, including six essential medications (insulin vials, heparin and low molecular weight heparins, hypertonic sodium chloride solutions, concentrated potassium injections, concentrated magnesium injections, and oral chemotherapeutic agents) and 10 optional medications (insulin pens, oral anticoagulants, immunosuppressants, parenteral nutrients for central veins, parenteral chemotherapeutic agents, parenteral benzodiazepines, contrast agents, phenytoin, epinephrine injections, and oral digoxin). Conclusion : We developed a list of high-alert medications for LTC settings at the national level, which may improve medication use and safety in patients who receive LTC.
참고문헌 (13)
- NM Wilson, "Medication safety in residential agedcare facilities : a perspective", Ther Adv Drug Saf, 1(1), pp.11~20 (2010)
- JH Gurwitz, "Incidence and preventability of adverse drug events in nursing homes", Am J Med, 109(2), pp.87~94 (2000)
- ND Barber, "Care homes’ use of medicines study : prevalence, causes and potential harm of medication errors in care homes for older people", Qual Saf Health Care, 18(5), pp.341~346 (2009)
- MJ Otero, "Developing a list of high-alert medications for patients with chronic diseases", Eur J Intern Med, 25(10), pp.900~908 (2014)
- I Dumitrescu, "High-risk medication in community care : a scoping review", Eur J Clin Pharmacol, 76(5), pp.623~638 (2020)
- A Sheikh, "The third global patient safety challenge : tackling medication-related harm", Bull World Health Organ, 95(8), pp.546~ (2017)
- MI Zafar, "Suitability of APINCH highrisk medications use in diabetes mellitus", Eur J Pharmacol, 867, pp.172845~ (2020)
- "Formulary and Prescribing Guidelines" (2019)[URL]
- "ISMP List of High-Alert Medications in long-term care (LTC) settings" (2021)[URL]
- 김경숙, "요양병원 인증 2주기 당면과제 및 해결방안", 병원경영학회지, 21(3), pp.65~70 (2016), 한국병원경영학회
- Korea Institute for Healthcare Accreditation, "Revised geriatric hospital accreditation standards", Korea Ministry of Health and Welfare, ~ (2021)
- 한지민, "국내 급성기 의료기관 고위험 의약품 목록 도출", 한국임상약학회지, 32(2), pp.116~124 (2022), 한국임상약학회[DOI]
- M Koronkowski, "An Update on Geriatric Medication Safety and Challenges Specific to the Care of Older Adults", Ann Longterm Care, 24(3), pp.37~40 (2016)